News

Spinal bulbar muscular atrophy (SBMA) is a progressive genetic neuromuscular condition that affects motor neurons. Over time, it may cause symptoms such as difficulty speaking, swallowing ...
SBMA is an X-linked inherited neuromuscular disorder ... "AnnJi reports outcomes from trial of spinal bulbar muscular atrophy therapy" was originally created and published by Clinical Trials ...
About Spinal and Bulbar Muscular Atrophy Spinal and bulbar muscular atrophy (“SBMA”) is a rare, X-linked genetic neuromuscular disease primarily affecting men. The condition is caused by the ...
Spinal and bulbar muscular atrophy (SBMA) is a rare X-linked neuromuscular disorder that results from an abnormal expansion of gene sequences in the androgen receptor gene. SBMA has an adult onset ...
The artist had suffered from dysarthria due to bulbar neuromuscular syndrome, a disease that makes it difficult to speak and breathe, which kept him off the stage for the last 10 years.
Journal of Neuromuscular Diseases ... them to suggest routine assessment and earlier intervention. Impact of bulbar dysfunction studied The Dutch team undertook this longitudinal study to assess ...
About Spinal and Bulbar Muscular Atrophy (SBMA) and NIDO-361 SBMA, also known as Kennedy’s disease, is a rare inherited X-linked neuromuscular disorder caused by a genetic mutation of the ...
The European Medicines Agency has granted orphan drug designation to a small molecule intended to treat spinal and bulbar muscular ... this rare and debilitating neuromuscular disease,” Vissia ...
MIAMI, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on ...